Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
Melanotan-I
Batch #
N/A
Formula
C78H111N21O19
Mol Wt
1646.8 g/mol
CAS
75921-69-6
Latest
ISO 17025
8× Testing
99.6%
Purity
VariantMelanotan I
COA ##13132
Labeled10mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.6%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - Melanotan I
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Afamelanotide for erythropoietic protoporphyria
02
Afamelanotide (CUV1647) for the treatment of erythropoietic protoporphyria
03
Afamelanotide in polymorphous light eruption: a randomized controlled trial
04
SCENESSE (afamelanotide) — FDA Approval for Erythropoietic Protoporphyria
05
Melanocortins and photoprotection: the role of MC1R in erythropoietic protoporphyria
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
